RECURRENT OR PROGRESSIVE ENDOMETRIAL CANCER

Clinical trials for RECURRENT OR PROGRESSIVE ENDOMETRIAL CANCER explained in plain language.

Never miss a new study

Get alerted when new RECURRENT OR PROGRESSIVE ENDOMETRIAL CANCER trials appear

Sign up with your email to follow new studies for RECURRENT OR PROGRESSIVE ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for women with Tough-to-Treat endometrial cancer

Disease control Recruiting now

This study is testing whether a new drug called Rina-S works better than standard chemotherapy options for women whose endometrial cancer has returned or worsened after prior treatment. About 544 participants will be randomly assigned to receive either Rina-S or one of two standa…

Matched conditions: RECURRENT OR PROGRESSIVE ENDOMETRIAL CANCER

Phase: PHASE3 • Sponsor: Genmab • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

RECURRENT OR PROGRESSIVE ENDOMETRIAL CANCER

Get alerted when new RECURRENT OR PROGRESSIVE ENDOMETRIAL CANCER trials appear

New hope for women with Tough-to-Treat endometrial cancer